The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key markets has introduced significant risk . Investors are now grappling with the impact of rival med